Anastasia Zafeiriadou | Polymerase Chain Reaction | Research Excellence Award

Published on by Medical Lab Scientist

Dr. Anastasia Zafeiriadou | Polymerase Chain Reaction | Research Excellence Award

Post Doctoral Researcher | National and Kapodistrian University of Athens | Greece

Dr. Anastasia Zafeiriadou is an analytical chemist and researcher whose work focuses on molecular diagnostics, wastewater-based epidemiology, and advanced assay development for public health surveillance. Her research integrates PCR- and droplet digital PCR–based methodologies for the sensitive detection and quantification of viral pathogens and antimicrobial resistance genes in environmental matrices, contributing to improved monitoring of infectious disease dynamics at the population level. She has authored 6 peer-reviewed research documents, published in high-impact international journals spanning analytical chemistry, environmental science, genomics, and oncology, reflecting strong interdisciplinary engagement. Her scholarly output has received 39 citations, with a h-index of 4, underscoring the relevance and growing impact of her contributions. Her research portfolio also includes earlier work on circulating tumor cells, metabolism-related gene expression, and biomarker evaluation, demonstrating methodological rigor and translational relevance. Collectively, her work advances analytical and molecular tools that support epidemiological surveillance, environmental monitoring, and precision diagnostics.

Citation Metrics (Scopus)

40

30

20

10

0

 

39
Citations

6
Documents

4
h-index

Citations

Documents

h-index

Featured Publications

Semiha Yenigun | Biochemistry | Editorial Board Member

Published on by Medical Lab Scientist

Dr. Semiha Yenigun |  Biochemistry | Editorial Board Member

Doctor | University of Ondokuz Mayis | Turkey

Dr. Semiha Yenigün is a distinguished researcher in the field of bioactive natural compounds and medicinal chemistry, with a Ph.D. in Chemistry from Ondokuz Mayıs University, Turkey (2023). Her research primarily focuses on phytochemical analysis, enzyme inhibition, antioxidant mechanisms, and molecular docking studies of plant-derived compounds, particularly from the Nepeta genus and other medicinal species. Dr. Yenigün has extensively explored bioactivity-guided fractionation, DNA protection assays, and in silico molecular dynamics and MM-PBSA analyses to evaluate structure–activity relationships of bioactive molecules. She has co-authored numerous publications in high-impact journals such as the Journal of Biomolecular Structure & Dynamics, ChemistrySelect, and Journal of the Indian Chemical Society. Her studies integrate computational chemistry and experimental biochemistry to identify potential therapeutic agents with antioxidant, antimicrobial, and enzyme inhibitory properties. Dr. Yenigün has contributed significantly to TÜBİTAK-funded projects including investigations on Nepeta baytopii and Elaeagnus umbellata, emphasizing the biotechnological production and characterization of triterpenoids and other phytochemicals. Her scholarly output demonstrates a strong command of molecular modeling, pharmacokinetic analysis, and bioinformatics applications in natural product chemistry, establishing her as an emerging expert in structure-based drug discovery and natural compound bioactivity evaluation.

Profiles: Scopus | ORCID | Google Scholar 

Featured Publications

Bechan Sharma | Biochemistry | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Dr. Bechan Sharma |  Biochemistry | Best Researcher Award

Professor | University of Allahabad | India

Dr. Bechan Indrajit Sharma is a highly accomplished scholar and researcher associated with the University of Allahabad, Prayagraj, India. Over the course of his distinguished career, he has made significant contributions to the fields of biochemistry, molecular biology, and environmental toxicology. His extensive research output includes 171 published documents, reflecting his deep engagement with scientific inquiry and academic excellence. With an impressive total of 5,328 citations  and an h-index of 37, Dr. Sharma has established himself as an influential figure in his area of expertise. His research has not only advanced understanding in critical areas of biological sciences but also addressed important environmental and health-related challenges. Through collaborations with over 300 co-authors, he has fostered interdisciplinary and cross-institutional partnerships, contributing to the global scientific dialogue. Dr. Sharma’s academic journey at the University of Allahabad is marked by his dedication to teaching, mentoring, and guiding young researchers toward innovation and scientific rigor. His work demonstrates a commitment to high-impact research that bridges theory and application, benefiting both academia and society. Known for his meticulous approach and passion for discovery, Dr. Sharma continues to inspire future generations of scientists through his research excellence and leadership in academia. His scholarly achievements and influence make him a prominent voice in the scientific community, reflecting a career devoted to advancing knowledge, fostering collaboration, and promoting sustainable scientific growth on both national and international levels.

Profiles: Scopus | ORCID | Google Scholar 

Featured Publications

Véronique LADEVEZE | Molecular Biology | Best Researcher Award

Published on by Medical Lab Scientist

Assist. Prof. Dr. Véronique LADEVEZE | Molecular Biology | Best Researcher Award

Dr at University of Poitiers, France

Dr. Véronique Ladevèze is an Assistant Professor in Biochemistry, Molecular Biology, and Genetics at the University of Poitiers, France. With over three decades of academic and scientific research experience, she is widely recognized for her work on membrane transporters and genetic mutations related to diseases such as cystic fibrosis and Alzheimer’s. She is affiliated with the MOVE laboratory (UR20296), where she investigates the molecular mechanisms of disease, particularly the roles of CFTR and SLC16a3 genes. Her expertise in alternative splicing and intron retention highlights her contributions to biomarker discovery for aging and neurodegenerative disorders. Dr. Ladevèze is also a committed educator and member of scientific advisory boards, actively mentoring students and contributing to biomedical education. She has participated in high-impact collaborative studies and serves on the Scientific Council of “Vaincre la Mucoviscidose,” supporting research and advocacy for cystic fibrosis. Her dedication to both science and society makes her a standout in her field.

profile

scopus

Education

Dr. Ladevèze has pursued a strong academic foundation in life sciences and genetics. She earned her Doctorate (Ph.D.) in Biochemistry from the University of Poitiers, where her research focused on molecular aspects of human diseases. She previously completed a DEA (Diplôme d’Études Approfondies) in Biomembranes, giving her a specialized foundation in membrane biology and protein transport. Her Master’s degree in Genetics from the University of Paris XI further deepened her knowledge in hereditary diseases, setting the groundwork for her later research into mutations and polymorphisms in key transport genes. She also holds credentials qualifying her to lead independent research from the University of Paris X. Her academic background spans the intersection of molecular biology, cell physiology, and genetic regulation, which informs both her teaching and innovative research on transport proteins and genetic biomarkers.

Experience

Dr. Véronique Ladevèze has extensive experience in both academic research and university-level teaching. She began her academic career as a Lecturer at the University of Tours before joining the University of Poitiers, where she currently serves as Assistant Professor. Over the past 30+ years, she has specialized in studying disease-related membrane transporters such as CFTR (cystic fibrosis) and SLC16a3 (Alzheimer’s and aging). Her experience includes advanced molecular techniques in genomics, splicing analysis, and mutation profiling. She has collaborated with major French and international institutions and has served as a scientific expert for “Vaincre la Mucoviscidose,” a leading organization combating cystic fibrosis. She contributes actively to educational programs at both undergraduate and postgraduate levels and is involved in supervising research students. Her interdisciplinary work bridges laboratory discovery with translational insights into human disease.

Awards and Honors

Dr. Ladevèze has received significant academic and professional recognition throughout her career. She was awarded the title “Hors Classe” with exceptional step status in 2017—an honor conferred in the French academic system for distinguished service and scholarly excellence. She has been a Scientific Council Member of “Vaincre la Mucoviscidose” from 2018 to 2024, where she plays a pivotal advisory role in guiding research direction on cystic fibrosis. Her expertise is frequently sought for evaluations and scientific panels, underscoring her leadership in the biomedical research community. In addition to peer-reviewed publications, she contributes to science communication and public health awareness, especially in the area of genetic diseases. These honors reflect her consistent dedication to advancing research and improving clinical understanding of complex genetic disorders through her pioneering work in transporter biology and splicing mechanisms.

Research Focus

Dr. Ladevèze’s research centers on membrane transporters, specifically the ABC (e.g., CFTR) and SLC (e.g., SLC16a3/MCT4) protein families. Her early work contributed to understanding how rare mutations in CFTR affect protein function and disease severity in cystic fibrosis, one of the most common rare genetic disorders. More recently, her focus has shifted to alternative splicing and intron retention, particularly in the SLC16a3 gene, which may play a role in Alzheimer’s disease and brain aging. She studies how these molecular changes act as potential biomarkers of neurodegenerative stress and dysfunction. Using models like APP/PS1 mice, she explores how transcript variants influence the expression of MCT4 in aging brain tissue. Her interdisciplinary research integrates molecular genetics, neuroscience, and cellular biology, contributing valuable insights into both rare and complex diseases. Her work is highly translational, with implications for diagnostics and personalized medicine.

Skills

Dr. Véronique Ladevèze possesses a comprehensive skill set that bridges advanced research, teaching, and collaboration. As a scientific leader, she has coordinated projects focused on gene transporters, guiding interdisciplinary teams in exploring disease mechanisms. Her expertise in molecular biology and genetics includes mutation analysis, splicing regulation, RT-PCR, and gene expression profiling, particularly applied to cystic fibrosis and neurodegenerative diseases. Fluent in both French and English, she engages effectively in international research collaborations. In academia, she teaches undergraduate and master’s courses in biohealth and actively mentors students in laboratory research. Dr. Ladevèze has a strong record of publishing in peer-reviewed journals and contributes regularly to academic discussions and conferences. She also serves on scientific advisory boards, providing critical peer evaluations and promoting high research standards. Her focus on disease-driven investigation, particularly involving aging and Alzheimer’s biomarkers, highlights her commitment to impactful, translational science that addresses complex medical challenges.

Publications

  • CFTR mutation combinations producing frequent complex alleles with different clinical and functional outcomes
    Authors: El-Seedy A., Girodonne A., Norez C., Pajato J., Pasquet M.-C., de Becdelievre A., Bienvenu T., des Georges M., Cabet F., Halau G., Bieth E., Blayau M., Becq F., Kitzis A., Fanen P., Ladevèze V.
    Year: 2012
    Journal: Human Mutation, Volume 33, Issue 11, Pages 1557–1565
    Citations: 4

  • Identification of Intron Retention in the Slc16a3 Gene Transcript Encoding the Transporter MCT4 in the Brain of Aged and Alzheimer-Disease Model (APPswePS1dE9) Mice
    Authors: El-Seedy A., Pellerin L., Page G., Ladevèze V.
    Year: 2023
    Journal: Genes, Volume 14, Issue 10, Article 1949
    Citations: 4

Conclusion

Dr. Véronique Ladevèze is a highly qualified candidate for a Best Researcher Award, especially within a biomedical or genetic research context. Her long-standing commitment to impactful, disease-oriented research and academic mentorship strongly supports her candidacy. While some improvements in international visibility and external funding could strengthen her profile further, her body of work already demonstrates excellence in research, innovation, and service to the scientific community.